| Peptide-based therapeutics: quality specifications, regulatory considerations, and prospects S Rastogi, S Shukla, M Kalaivani, GN Singh Drug discovery today 24 (1), 148-162, 2019 | 63 | 2019 |
| Veterinary herbal medicines in India S Rastogi, MK Pandey, J Prakash, A Sharma, GN Singh Pharmacognosy Reviews 9 (18), 155, 2015 | 39 | 2015 |
| Efficacy and safety of filgrastim and its biosimilars to prevent febrile neutropenia in cancer patients: a prospective study and meta-analysis S Rastogi, V Kalaiselvan, S Ali, A Ahmad, SA Guru, M Sarwat Biology 10 (10), 1069, 2021 | 18 | 2021 |
| Towards a comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars in treating chemotherapy associated febrile neutropenia: Trends from decades … S Rastogi, S Shukla, AK Sharma, M Sarwat, P Srivastava, T Katiyar, ... Toxicology and Applied Pharmacology 395, 114976, 2020 | 12 | 2020 |
| Development and validation of a liquid chromatography method for determination of embelin in crude extract of Embelia ribes S Rastogi, AK Bhatia, A Kushwaha, MK Pandey, A Sharma, J Prakash, ... Asian Journal of Biomedical and Pharmaceutical Sciences 4 (36), 9, 2014 | 11 | 2014 |
| Severe cutaneous adverse reactions in Asians: Trends observed in culprit anti-seizure medicines using VigiBase® S Shukla, S Rastogi, SAH Abdi, P Dhamija, V Kumar, V Kalaiselvan, ... Seizure 91, 332-338, 2021 | 9 | 2021 |
| Anti-cancer activity of guggulsterone by modulating apoptotic markers: a systematic review and meta-analysis M Gupta, D Singh, S Rastogi, HR Siddique, N Al-Dayan, A Ahmad, ... Frontiers in Pharmacology 14, 1155163, 2023 | 6 | 2023 |
| Comparative study of adverse drug reactions associated with filgrastim and pegfilgrastim using the EudraVigilance database S Rastogi, V Kalaiselvan, YA Bin Jardan, S Zameer, M Sarwat Biology 11 (2), 340, 2022 | 6 | 2022 |
| Adverse reactions after hepatitis B vaccination: a retrospective analysis using spontaneous reports M Kalaivani, S Rastogi, V Kalaiselvan, GN Singh Journal of Young Pharmacists 9 (1), 55, 2017 | 6 | 2017 |
| Pharmacopoeia roles and responses: A systemic resilience approach to COVID-19 pandemic S Rastogi, SK Sharma, J Chauhan, PK Saini, R Kumar, RS Raghuvanshi, ... Saudi Pharmaceutical Journal 30 (5), 613-618, 2022 | 5 | 2022 |
| Implementing the Principle of the 3Rs Through the Indian Pharmacopoeia S Rastogi, M Kalaivani, AK Bhatia, J Prakash, GN Singh Therapeutic Innovation & Regulatory Science 49 (5), 750-755, 2015 | 4 | 2015 |
| Retrospective analysis of neoplasms in patients using angiotensin receptor blockers AK Sharma, S Rastogi, RK Goyal Scientific Reports 14 (1), 15774, 2024 | | 2024 |
| 1 Regulatory of Quality Control Aspects S Rastogi, GPS Jadaun Quality Control and Regulatory Aspects for Biologicals: Regulations and Best …, 2024 | | 2024 |
| A comprehensive quality control and cost comparison study of branded and generic angiotensin receptor blockers AK Sharma, S Rastogi, F Ali, AP Yadav, RK Goyal Saudi Pharmaceutical Journal 32 (3), 101985, 2024 | | 2024 |
| Ensuring the quality of medicines in India: An update on the development, modernization, and harmonization of drug standards in the Indian Pharmacopoeia GPS Jadaun, S Rastogi, A Kumar, J Chauhan, SK Sharma, M Kumar, ... Saudi Pharmaceutical Journal, 101825, 2023 | | 2023 |
